Clinical Trial:

Cell harvesting (ReCell) for scar healing

Full Name

Scars (CTP002-1): A study of the ReCell® Autologous Cell Harvesting Device for healing of dermabraded scars: a feasibility study (1_PRO00000098)

Description

Participants whose scar(s) meet specific criteria will receive local or general anesthesia in preparation for dermabrasion. A small area of skin that best matches the non-scarred skin will be shaved off for processing in the ReCell device. One part of the scarred area will be sprayed with the ReCell-produced cell suspension, while a second area (or 2nd scar if scars are small) will receive standard of care treatment. A week after surgery, participants will return for a physical exam and blood test, at which time photographs will be taken of the healing wounds. This review will be repeated at 10 days, 2 weeks, 3 weeks, 4 weeks, 12 weeks and at 6 months.

Eligibility

Inclusion Criteria
  • Must have scars of sufficient size and pattern
  • Age 18 years or older
  • Able and willing to follow the protocol treatment and follow-ups
  • Able to provide voluntary written informed consent
  • Must abstain from any treatment of the scar other than is directed by the surgeon-investigator for study duration, unless medically necessary
  • Must not be pregnant or lactating
  • No pre-existing conditions that may interfere with wound healing
  • Adequate organ functions
Doctor(s) Running This Study

Specialties

  • Burn Surgery
  • Burn Recovery and Wound Care

Affiliated with

LVPG Cliniciani

Accepting New Patients